AU2007217119A1 - Enzyme detection - Google Patents
Enzyme detection Download PDFInfo
- Publication number
- AU2007217119A1 AU2007217119A1 AU2007217119A AU2007217119A AU2007217119A1 AU 2007217119 A1 AU2007217119 A1 AU 2007217119A1 AU 2007217119 A AU2007217119 A AU 2007217119A AU 2007217119 A AU2007217119 A AU 2007217119A AU 2007217119 A1 AU2007217119 A1 AU 2007217119A1
- Authority
- AU
- Australia
- Prior art keywords
- zone
- visualisation
- enzyme
- reaction
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/505—Containers for the purpose of retaining a material to be analysed, e.g. test tubes flexible containers not provided for above
- B01L3/5055—Hinged, e.g. opposable surfaces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/069—Absorbents; Gels to retain a fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0887—Laminated structure
Description
WO 2007/096642 PCT/GB2007/000643 1 ENZYME DETECTION The present invention relates to an enzyme detection product and also to a method for detecting the presence of an enzyme. 5 It is known in the art to detect the presence of enzymes under a variety of circumstances. Aside from laboratory methods, kits have been provided which allow the detection of specific enzymes, or types of enzymes without specialist equipment. 10 For example, it has been disclosed to provide a kit for use by a dentist in order to analyse the gingival crevicular fluid of a patient for the presence of a protease enzyme. A sample of the fluid is taken from the patient and is placed on a filter paper namely loaded with a primary reactant namely the synthetic peptide known as BANA (Na- benzoyl-dl-Arg E-naphthylamide). As is shown in Figure 1, in the presence of a 15 protease, a napthylamine moiety is cleaved from the BANA peptide. Another portion of the filter paper is loaded with a secondary reactant DMAC (Dimethyl amino cinnamaldehyde). In response to the presence of the cleaved napthylamine moiety and HCI, DMAC changes colour (from colourless to pink/red). In use, the filter paper is folded over bringing the area loaded with DMAC into contact with the area loaded 20 with BANA and sample, to permit mixing thereof and any colour change is observed. If a colour change occurs then this is an indication that a protease is present in the patient's sample. While such prior art detection systems work acceptably well, they have several 25 problems in their wider applicability. One problem is that, while gingival crevicular fluid is generally clear, other'samples may not be clear and therefore it is more difficult to observe the colour change which may be taking place. For example, if the sample is blood, or contaminated with blood, then it has a strong background colour of its own which may obscure the colour which is produced in the reaction. 30 Another problem with such prior art systems is that they are susceptible to providing false positive results because the sample, itself, may contain the components which will react with the secondary reactant in order to provide the colour change or other WO 2007/096642 PCT/GB2007/000643 2 signal. With some chromagenic systems colour may be generated through reactions with amino acids or short peptides (e.g ninhydrin). For instance, to continue the example given above, the gingival crevicular fluid sample may contain a free primary aromatic amine group or an analogue thereof which can react with the DMAC in 5 order to result in a colour change even when no protease is present and the BANA peptide has not been cleaved. The present invention seeks to alleviate one or more of the above problems. 10 According to one aspect of the present invention there is provided an enzyme detection product for detecting the presence of an enzyme in a sample comprising: a reaction zone for receiving a sample; a visualisation zone for presenting a signal in response to the detection of the activity of the enzyme, wherein the reaction zone comprises 15 a reactant capable of reacting with the enzyme in order to generate a reaction product. The reaction zone is pre-treated with the reactant. 20 Preferably, the product further comprises a membrane interposable between the reaction zone and the visualisation zone, the membrane preventing passage from the reaction zone to the visualisation zone of components having a size greater than a threshold size and wherein the reaction product has a size less than the threshold size. 25 The membrane has a molecular weight threshold. This is preferably of less than 1OOkDa, 50kDa, 1OkDa, 5kDa, 1kDaor500Da. Conveniently, the membrane is opaque. 30 Preferably, the reaction zone and/or the visualisation zone comprise films made of an absorbent material which hydrates but does not dissolve in the presence of water.
WO 2007/096642 PCT/GB2007/000643 3 Advantageously, the film is made from PVA, pectin, acrylamide, agarose, pululan or a carrageenan. Conveniently, the visualisation zone is made from a material which allows uniform 5 colour development. Preferably, the reaction zone and the visualisation zone are hingedly connected to each other and may be brought into contact with each other by flexing about the hinge. 10 Advantageously, at least one of the reaction zone and visualisation zone has an adhesive area extending around its perimeter for sealingly contacting the reaction zone with the visualisation zone. 15 Conveniently, the visualisation zone is mounted on a leaf, there being provided an aperture in the leaf, for viewing of the visualisation zone. Preferably, the aperture is covered by a transparent window. 20 Advantageously, the reaction zone has a sump made from an absorbent material located adjacent to it. Preferably, a layer is located between the reaction zone and the sump, such as an adhesive layer. It is particularly preferred that the layer extends laterally outwardly of 25 the reaction zone. For example, if the reaction zone and the layer are circular then the layer has a greater diameter than the reaction zone. Conveniently, at least one of the reaction zone and visualisation zone is covered by a removable protective film. 30 Preferably, the visualisation zone comprises a second reactant capable of reacting with the reaction product to generate the signal.
WO 2007/096642 PCT/GB2007/000643 4 Advantageously, the enzyme is a protease; the first reactant being the BANA peptide and the second reactant being D-MAC. Conveniently, the enzyme detection product further comprises a sample dispersion 5 means for facilitating the lateral movement of the sample; breaking up the surface of the reaction zone and forming channels therein to conduct the sample therethrough. According to another aspect of the present invention, there is provided a method of detecting the presence of an enzyme in a sample comprising the steps of: 10 i) contacting the sample with a first reactant, the reactant producing a reaction product in the presence of the enzyme; ii) separating at least some of the components in the mixture which are smaller than a threshold size into a visualisation zone, the reaction 15 product being smaller than the threshold size; and iii) detecting the presence of the reaction product in the visualisation zone. 20 Conveniently, step ii) comprises using a selective membrane to separate components in the mixture. Preferably, step ii) comprises observing the reaction product or a signal released by the reaction product. 25 Advantageously, step i) is carried out on a reaction substrate and step iii) is carried out on a visualisation substrate. Conveniently, the method further comprises the step of, after step i), contacting the 30 reaction substrate with the visualisation substrate. Preferably, step iii) comprises providing a second reactant, which reacts with the reaction product to generate a signal.
WO 2007/096642 PCT/GB2007/000643 5 Advantageously, the method uses an enzyme detection product of the invention. In order that the present invention may be more readily described and so that further 5 features of the invention may be understood, embodiments of the invention shall now be described by way of example, with reference to the accompanying drawings in which: FIGURE 1 is a schematic diagram of the reaction of a protease enzyme, BANA and 10 DMAC; FIGURE 2 is a perspective view of an enzyme detection product in accordance with one embodiment of the invention; 15 FIGURE 3A is a cross-sectional view along the line A-A of the enzyme detection product shown in FIGURE 2; and FIGURE 3B is a cross-sectional view of the enzyme detection product of FIGURE 2 along the line B-B; 20 FIGURE 4 is a schematic cross-sectional view of an enzyme detection product according to an alternative embodiment; FIGURE 5 is a graph showing colour development of an enzyme detection product 25 according to one embodiment; FIGURE 6 is a plan view of a colourimeter used in the test whose results are shown in Figure 5; 30 FIGURE 7 is an image of an enzyme detection product according to another embodiment, following usage; WO 2007/096642 PCT/GB2007/000643 6 FIGURE 8 is an image of an enzyme detection product according to another embodiment, following usage; FIGURE 9 is graph showing colour development of an enzyme detection product 5 according to another embodiment; FIGURE 10 is graph showing colour development of an enzyme detection product according to another embodiment; 10 FIGURE 11 is an image of an enzyme detection product according to another embodiment, following usage; FIGURE 12 is an image of an enzyme detection product according to another embodiment, following usage; 15 FIGURE 13 is a cross-sectional diagram of an enzyme detection product according to a further embodiment; and FIGURE 14 is an image of an enzyme detection product according to another 20 embodiment, following usage. Referring to FIGURE 2, an enzyme detection product 1 comprises a paper or cardboard book 2 comprising first and second leaves 3,4 of identical shape and size connected at a spine 5. Thus the spine 5 acts as a hinge between the first and 25 second leaves 3, 4. In the centre of the first leaf 3, there is provided a first aperture 6 in the book 2. On top of the first leaf 3, covering the aperture 6 is provided a visualisation pad 7 which is covered by a protective film prior to use (not shown). 30 Referring now to FIGURE 3A, the visualisation pad 7 will be described in greater detail. The internal face of the first leaf 3 carries a first adhesive film 8, in which there is an aperture 9 aligned with, but larger than, the first aperture 6. On top of the first WO 2007/096642 PCT/GB2007/000643 7 adhesive film 8 is provided a visualisation film 10 made from polyvinyl alcohol (PVA) which hydrates but does not dissolve in the presence of water. The visualisation film 10 contains DMAC and HCI within its structure. The visualisation film 10, though centred on the aperture 6, is smaller than the first adhesive film 8. The visualisation 5 film 10 is optically clear, carries no inherent colour and allows uniform colour development. It is non-porous before use. On top of the visualisation film 10 is provided a membrane 11, which is bigger than the film 10 and thus overlaps the visualisation film 10 and connects at its edges onto 10 the first adhesive film 8. Nonetheless, the membrane 11 is smaller than the first adhesive film 8 so that the edges 12 of the first adhesive film 8 extend outwardly from the membrane 11. The membrane 11 is opaque and is preferably white in colour. It contains a plurality of pores (not shown). The pores render the membrane selective of the molecules which may pass through it. More specifically, molecules having a 15 molecular weight of above a threshold size of 500 daltons cannot pass through the membrane 11, but molecules having a molecular weight of less than 500 daltons may pass through the membrane. In alternative embodiments, the threshold size is greater than 500Da and may, for example be 1 kDa or 5kDa. 20 The second leaf 4 has a reaction pad 13 located in its centre. The reaction pad 13 is located on the second leaf 4 facing the visualisation pad 7 of the first leaf 3. Covering the reaction zone 13 is a removable foil wrapper (not shown). Referring now to FIGURE 3B, the reaction pad 13 will be described in further detail. 25 The reaction pad 13 comprises, attached to the second leaf 4, a second adhesive film 14. On top of the adhesive film 14 (although of a smaller size than the adhesive film 14) is provided an absorbent sump 15. On top of the absorbent pad 15 is provided a reaction film 16 made from polyvinyl alcohol (PVA) and having impregnated into it the synthetic peptide BANA and a sample dispersion material. 30 The sample dispersion material is a fabric which facilitates the lateral movement of the sample on the reaction film 16 by breaking up the surface of the reaction film 16 and forming channels in it through which the sample can be conducted. The reaction film 16 is of the same size as the visualisation film 10 and is thus smaller than the WO 2007/096642 PCT/GB2007/000643 8 absorbent sump 15 such that the edges 17 of the second adhesive film 14 extend outwardly of the reaction film 16. In order to use the enzyme detection product 1, the book 2 is opened to separate the 5 first and second leaves 3,4 and the protective films (not shown) covering the visualisation pad 7 and the reaction pad 13 are removed. The sample to be tested (e.g. blood) is deposited on the reaction film 16. Any run-off from the sample is absorbed by the sump 15. The first and second leaves 3,4 of the book 2 are pressed together after an appropriate reaction time (e.g. 60 seconds), such that the edges 12 10 of the first adhesive film 8 meet the edges 17 of the second adhesive film 14 and cause adhesion between the first and second leaves 3,4. The adhesion of the first and second leaves 3,4 to each other seals the sample within the book 2, which thus hygienically contains the sample. 15 It is to be noted that, as soon as the sample is placed upon the reaction film 16, any protease enzyme active in the sample will begin hydrolysing the BANA peptide and releasing the napthylamine moiety even before the leaves 3,4 are brought together. The napthylamine moiety is small enough to pass through the membrane 11 and onto the reaction film 10. Other components of the sample which have a molecular 20 weight bigger than the threshold size of 500 daltons are unable to pass through the membrane 11. When the napthylamine moiety reaches the visualisation film 10, the DMAC and napthylamine condense and change colour to red/pink (see Figure 1). The 25 visualisation film 10 is visible through the first and second apertures 6,9 in the first leaf 3 and the first adhesive film 8 and thus an observer may see the colour change that takes place. Because the membrane 11 is preferably white in colour, opaque and forms a background to the visualisation film 10, it assists an observer in making an unbiased assessment of the colour change, regardless of sample-derived 30 interfering colour. The colour change is indicative of the presence of a protease enzyme in the sample. The degree of colour change (hue, saturation and absorbance) and the rate of colour change (although not necessarily both) are dependent on the enzyme concentration in the sample and reaction time.
WO 2007/096642 PCT/GB2007/000643 9 In a sample without protease activity, the napthylamine moiety is not released from the reaction film 16, so when the two leaves 3,4 of the book I are brought into contact, the DMAC compound reacts with HCI present in the visualisation film 10 in 5 the presence of the fluid sample to produce a yellow coloured product. In an alternative embodiment of the invention, a transparent slide or window is attached to the first leaf 3, covering the first aperture 6, on the opposite side of the first leaf 3 from the first adhesive film 8. The transparent slide permits viewing of the 10 visualisation film 10, but does not permit ingress of contaminants or egress of the sample. In alternative embodiments, the reaction film 16 and the visualisation film 10 are instead made from other materials which hydrate but do not dissolve in water such as 15 acrylamide, agarose, pululan or carrageenans. It is to be understood that the present invention is not limited to embodiments in which the reaction film 16 is impregnated with BANA peptide and the visualisation film 10 is impregnated with DMAC. Instead, a different set of reactants may be 20 provided on the reaction film 16 and the visualisation film 10, respectively. For example, DMAC can also be replaced with Fast Garnet (a zinc stabilised diazonium salt) or Fast Black. 25 Alternatively, the napthylamide group of BANA can be attached to any amino acid sequence of choice to enable detection of particular proteases. For example in order to test for the presence of the enzyme neutophil elastase BANA is replaced with H-DL-Ala-bNA (Bachem). 30 Reactants can be designed and synthesised for the detection of the presence of the activity of a particular protease enzyme using napthylamide or napthylamide ester labels.
WO 2007/096642 PCT/GB2007/000643 10 In alternative embodiments, the reactant casein is provided on the reaction film instead of BANA and the reactant ninhydrin is provided on the visualisation film instead of DMAC. 5 Indeed, it is not essential to the invention that any reactant is provided on the visualisation film 10. For example, referring to Figure 4, another embodiment is shown schematically. In Figure 4, like components have the same numbering as in the previous embodiments. Thus, in this embodiment the first and second leaves 3, 4 have a visualisation film 10 covered by a selective membrane 11 and a reaction 10 film 16, respectively. An aperture 6 is provided in the first leaf 3, above the visualisation film 10. The reaction film 16 is impregnated with a cleavable peptide 18 having a fluorophore group 19 covalently attached to one end 20 thereof and a quencher group 21 attached to the other end 22 of the peptide. The peptide 18 is sensitive to a protease enzyme, in that a protease enzyme will cleave the peptide 18 15 separating the first end 20 to which the fluorophore group 19 is conjugated from the search end 22 to which the quencher group 21 is conjugated. The cleaved first end 20 is small enough to pass through the membrane 11, away from the quencher 23 located on the remaining peptide 18, and into the visualisation film 10, where, under incident light 23 it may be observed to fluoresce visible light 24. However in the 20 absence of the protease in the sample, the peptide is not cleaved and the uncleaved peptide 18 is too big to pass through the membrane 11. Thus in this embodiment, the visualisation film 10 does not contain a component which reacts with any other component and instead acts as a receptacle and viewing area for the reaction product (i.e. the fluorophore group 21 bound to the first end 20). 25 An example of a suitable fluorophore group is Mca(7-methoxycoumarin-4-acetyl) and a suitable quencher is Dpa(2,4-Dinitrophenyl). Mca, when not in proximity to Dpa, can be detected fluorometrically at 392nm (excitation 325 nm). 30 In an alternative embodiment, the reactant in the reaction film 16 is a peptide, the carboxy end of which is linked via an amide bond to a p-Nitroanilide group. If the peptide is cleaved by a protease enzyme then this releases a p-nitroaniline group which passes through the membrane 11 and is visible as it is yellow in colour.
WO 2007/096642 PCT/GB2007/000643 11 In another embodiment, BANA is provided on the reaction film 16 but no DMAC is provided in the visualisation film 10. In the presence of a protease enzyme, napthylamine is released and is visible in the visualisation film under UV light. In a 5 further embodiment, the reactant provided on the reaction film 16 is DL arginine amino methyl L coumarin which also releases a fluorescent cleavage product in the presence of a protease enzyme. It is also to be understood that the present invention is not limited to products for the 10 detection of a protease enzyme. In other embodiments, reactants are provided on the reaction film 16 and, optionally also the visualisation film 10, which are responsive to other enzymes in a sample. For example, in one embodiment amylase is detected by the release of glucose from amylose in the reaction film 16. In this embodiment the visualisation film 10 contains glucose oxidase and an appropriate 15 chromogen, of a type widely known by those skilled in the art.
WO 2007/096642 PCT/GB2007/000643 12 EXAMPLES Example 1 - Elastase substrate in a booklet format 5 Materials (Film Preparation) H-Ala-Beta-napthylamide (H-Ala-PNA) 50mM tris buffer pH 8 10% Brij 35 in deionised water 10 5% PVA in deionised water Dimethylaminocinnamaldehyde (DMAC) Cotton gauze Dimethyl sulfoxide (DMSO) 3M HCL 15 Methanol (MEOH) Petri dishes 20cm Deionised water Materials (Device assembly and enzyme assay) 20 Cartridge paper Double sided adhesive tape DMAC film H-Ala-pNA film 25 Porcine pancreatic elastase Small colourimeter (Figure 6) connected to PC Method (Film preparation) 30 H-Ala-pNA film was prepared as follows; discs of gauze were cut to fit inside the base of a standard 18cm microbiological Petri dish. Further, 20mgs of H-Ala-pNA was weighed out and added to a universal bottle with 1ml of DMSO to dissolve. The following reagents were added to the dissolved substrate; 1.5mls of tris buffer, 100pl WO 2007/096642 PCT/GB2007/000643 13 of Brij 35 and 7.5mis of 5% PVA. The tube was gently inverted to facilitate mixing of the components before pouring the suspension into the Petri dish to cover the gauze. The open dish was placed in a fume hood to dry at ambient temperature for approximately 20 hours. 5 DMAC films were prepared as follows; 15mgs of DMAC weighed out and added to a universal with 1.5mls of MeOH to dissolve. 3.75mis of HCL was added followed by 2.25mls of deionised water and 7.5mis of 5% PVA. The components were mixed by inverting the tube prior to pouring into a clean empty Petri dish. The film was dried at 10 ambient temperature for approximately 20 hours in a fume hood. Method (device assembly) The cartridge paper was cut into rectangles of approximately 10x 5cm, these were 15 folded in half and the centre point was marked with a pencil on the front cover. A circular punch was used to cut a aperture approximately 12mm diameter in the front cover of the booklets. The hole was then used to mark the central location on the inside of the opposing leaf of the construction. Pieces of double sided tape were applied to the inner left and right hand sides. 20 Film (described above) was cut with circular punches; the H-Ala-PNA was cut with the 12mm diameter punch and applied to the inner right hand side sticky tape to give the sample application area. DMAC film was cut with a slightly larger punch approximately 15mm diameter and secured on the double sided tape on the inner left hand side to cover the aperture. 25 Enzyme assay Porcine pancreatic elastase (Sigma) was prepared to give approximately 20 mg/ml in Tris buffer pH 8. 30 Two devices were run, an enzyme negative sample was applied to device 1 and elastase positive sample was applied to second device. The devices were run consecutively by applying 40pl of sample to the substrate pad (H-Ala-pNA) and incubating for 10 minutes at room temperature. After the incubation period the WO 2007/096642 PCT/GB2007/000643 14 device was closed so that the DMAC film contacted the substrate pad and remained closed by the double sided tape. The colour development was monitored by placing the device viewing window down 5 onto a basic colourimeter. Readings were taken once per second over a total of 5 minutes. The resulting data was compared for Hue (H) and Saturation (S) by using the following equation: 1/H x S. Data can be seen in Figure 5. Stronger colours generated from a device treated with a positive sample (blue line) have a lower numerical value of H and often greater saturation i.e. S value. Negative samples 10 therefore have a lower flatter trend than positive samples (pink line). The colourimeter is shown in Figure 6. It consists of a white LED light source and colour sensing chip as detector in a black plastic case to remove ambient light. Components or the colourimeter are as follows: opening for reading devices with 15 white LED 30; power supply 31; connection to computer 32; on/off switch 33; and elastic bands to hold devices in place 34. Raw data is converted by embedded software to give Hue (H), Saturation (S) and Intensity (V) values as well as Red (R), Green (G) and Blue (B) to a terminal emulator application. The readings from the device are based on the colour wheel principle. 20 Example 2 - Fluorescent label detection following enzymatic cleavage of substrate. A. Detection of pNA as a flurophore. 25 Materials 5% PVA in deionised water Cotton gauze 30 Dimethyl sulfoxide (DMSO) Petri dishes 20cm Deionised water 250mM phosphate 25mM EDTA pH 7.2 WO 2007/096642 PCT/GB2007/000643 15 Benzoyl Arginine beta napthylamide. HCL (BANA) Petri dish Cartridge paper Double sided sticky tape 5 Method. BANA films were prepared as per the H-Ala-PNA film, but with subtle changes. Discs of cotton gauze were cut to fit the inside of a standard 18cm microbiological 10 petri dish. 20mg of BANA were added to a universal and dissolved in 1 ml of DMSO. The following reagents were added; 1 ml of phosphate/EDTA buffer 0.5 ml of deionised water and 7.5mls of 5% PVA. The suspension was mixed gently and then poured onto the gauze and placed in a fume hood to dry at ambient temperature for approximately 20 hours. 15 Testing A piece of cartridge paper approximately 12x5cm was prepared with small 5 small holes (approximately 5mm diameter). The holes were each covered with a small 20 square of double sided tape. BANA film was cut to fit the tape on the holes and applied. Prepared papain enzyme standards at 700, 350, 70, 7pgml in a deionised water with 0.01% cysteine, diluent. A negative of diluent only was also used. The enzyme and control samples were applied at 20pl per BANA film and incubated at room temperature. The progress of fluorescence development was checked at 25 approximately 5 minute intervals on a UV light box. The results after approximately 14 minutes are given in Figure 7 and are tabulated in Table 1.
WO 2007/096642 PCT/GB2007/000643 16 Table 1. Interpretation of fluorescent signal in Figure 7. (Fluorescent brightness is scored according to the negative.) 700pgml 350pgml 70pgml 7pgml Enzyme 0 Enzyme Enzyme Enzyme Enzyme Fluorescence was detected above the background in films that were incubated with 5 350 and 700pgml of papain. B. Detection of cleaved Bz-DL-Arq-Amino MethylCoumarin.HCL 10 Materials Bz-DL-Arg AMC.HCL (Bachem 1-1076) 5% PVA in deionised water Cotton gauze 15 Dimethyl sulfoxide (DMSO) Petri dishes 20cm Deionised water 250mM phosphate 25mM EDTA pH 7.2 Petri dish 20 Cartridge paper Double sided sticky tape Method 25 A film was prepared as described in 'A' with the following exception; 10mg of Bz-DL ArgAMC.HCL was added to the DMSO instead of BANA. Testing 30 Set up of the test device as previously described in 'A' with the following exception; three rows of 4 pieces of film were attached over the viewing windows instead of 1 row of 5.
WO 2007/096642 PCT/GB2007/000643 17 Applied fresh papain standards at the following concentrations, 10000, 1000, 1OOpgml and 0. Monitoring of the signal generation was as previous. The results are shown in Figure 8 and are tabulated in Table 2. 5 Table 2. Interpretation of fluorescent signal in Figure 8 (Fluorescent brightness is scored according to the negative). 10000pgml 1OOOpgmI Enzyme 1OOpgmI Enzyme 0 Enzyme Enzyme -H- + Fluorescence was detected at all levels of the enzyme tested. 10 Example 3 - Exemplification of BANA / DMAC Protease Assay using storage data Preparation of BANA and DMAC films. 15 The standard procedures are as follows: Materials Close weave cotton gauze 5% PVA in deionised water 20 Dimethyl sulfoxide (DMSO) Petri dishes 20cm Deionised water 250mM phosphate 25mM EDTA pH 7.2 Benzoyl Arginine beta napthylamide. HCL (BANA) 25 Petri dish 3M HCL Methanol (MEOH) DMAC 30 BANA / PVA I Gauze Film 1) A disc of cotton gauze was cut to fit the inside of a 20cm Petri dish. 2) 20mgs of BANA wad added to a clean universal and dissolved in 1 ml of DMSO.
WO 2007/096642 PCT/GB2007/000643 18 3) The following were added to the BANA stock prepare in (2), 1ml of phosphate/EDTA buffer, 0.5mls of deionised water and 7.5mls of 5% PVA. 4) The solution was mixed gently and then poured onto the gauze and placed in a fume hood to dry for approximately 20 hours. 5 DMAC / PVA Film 1) 15mgs of DMAC was weighed out and added to a clean universal with 1.5mls of MeOH to dissolve. 2) The following were added to the DMAC stock prepared in (1), 3.75mls of HCL was 10 added followed by 2.25mis of delonised water and 7.5mls of 5% PVA. 3) The components were mixed by inverting to tube prior to pouring into a clean empty Petri dish. The film was dried for approximately 20 hours in a fume hood. Preparation of Papain standards 15 1) A stock solution is prepared freshly each day when required to give 10mgml enzyme in deionised water with 0.1% cysteine. This stock solution is then used to prepare working strength standards by further dilution in deionised water. Preparation of Booklet Devices 20 1) Booklets prepared from cartridge paper folded to give a booklet of approximately 5x5cm. 2) In the centre of the front cover a 12cm diameter hole (viewing window 6) was punched. 25 3) Two pieces of double sided tape of approximately 25mm square were placed in the centre of both inside leaves of the booklet as adhesive films 8 and 14. 4) A 12mm diameter disc of BANA / PVA / Gauze film 16 was placed in the centre of the adhesive film 14 to be the sample application area. 5) A 15mm diameter disc of DMAC / PVA film 10 was placed in the centre of the 30 adhesive film 8 covering the viewing window 6. Enzyme Assay WO 2007/096642 PCT/GB2007/000643 19 Devices materials were prepared and assembled according to our standard methodologies described above. On day 0 (defined as the day materials were dry and ready for device assembly) devices were run to give day 0 results against which 5 stored materials could be compared. Solutions containing papain at concentrations of 500 and 5pgml and a negative of the diluent only (50pl volumes per test) were applied to devices for an incubation period of 10 minutes. The booklets were closed and the colour development was monitored using the Mologic booklet device colourimeter which measures the following parameters at 1 second intervals, Hue (H) 10 Saturation (S) Brightness (V) Redness (R) Greenness (G) and Blueness (B). Devices were stored at 4 0 C without a dessicant and assayed over the following 28 days with data for day 0 and day 28 listed below. 15 Data manipulation The colorimeter output measurement data for Hue and saturation were manipulated using the following equation: 1/HxS. The data are shown in Figures 9 and 10. Figure 9 shows a graph showing replicate data for the papain standards tested on day 0 20 devices. Figure 10 shows a graph showing replicate data for papain standards tested on day 28.
WO 2007/096642 PCT/GB2007/000643 20 Table 3 compares the calculated slopes and readings at certain time points. Table 3 Negative 5pg ml Papain 500pg ml Papain Slope Day 0 0.003 0.00865 0.103 Slope Day 28 0.007 0.010 0.107 Av.1/H*S day 0 60 seconds 0.569 0.921 7.731 90 seconds 0.614 1.149 7.917 120 seconds 0.649 1.364 8.00 Av.1/H*S day 28 60 seconds 0.897 0.876 6.745 90 seconds 0.956 1.093 7.580 120 seconds 1.028 1.288 7.828 5 The data illustrates a reduced rate of signal development in the day 28 positive samples. However, the comparison of the averaged data shows little significant change in the final signal values, in the case of positive samples this is achieved in a slightly longer time frame. 10 Example 4 - Evaluation of selective membranes into Booklet Assay Using the standard BANA/DMAC format booklet (as described in Example 3) the following 'selective' membranes have been incorporated into the device according to 15 Figure 3A except that the visualisation window 6 was completely sealed with the adhesive film 8 such that here is no aperture 9 to minimise evaporation during substrate incubation. A wide range of membranes evaluated in Protease Booklet ranging from a 0.22pm 20 pore size filters to a MWCO 3500Da dialysis membrane as listed below. Millipore Isopore membrane - 0.1 pm, 25pm thick VCTP Millipore MF membrane - 0.2pm, 150pm thick GSPW Millipore Durapore membrane - 0.22pm, 150pm thick GV WO 2007/096642 PCT/GB2007/000643 21 Whatman Nylon membrane - 0.2pm pore, 150pm thick Degussa ceramic composite membranes - type S240 P25 - 25pm thick Dialysis membranes - Pierce Snakeskin prod # 68035, MWCO 3,500 and Spectra/Por cat # 132723, MWCO 3,500 5 Amicon NMWL membrane - cat # PBCC 04310, NMWL 5,000 Booklets were prepared with each of the membranes as described above and then tested with 0, 50 and 250pg/ml Papain standards using sample volumes of 4 0pl for the control devices and 80pl for devices incorporating the membrane to ensure 10 sufficient liquid added to the device to wet all booklet components. Standards were added to the BANA film and incubated for 10 minutes. The booklets were then closed and colour development recorded by capturing digital images over a 30 minute period. 15 Figure 11 shows digital images of booklets without a selective membrane (control booklets) and with a MWCO 3,500 dialysis membrane following 15 minute incubation. The results are tabulated in Table 4. Table 4 - Signal Generation for Booklets incorporating Selective Membranes 20 Papain Standard Control Booklet Membrane Booklet Opg/ml 50pg/ml + + 250pg/ml ++++++ Example 5 - Evaluation of a Sink in the Booklet 25 Various sink formats were tested in the booklet type protease where in all cases the sink was larger than and placed beneath the BANA film which was held onto the sink using double sided tape. Two materials were tested, Fisherbrand QL 100 filter paper and Bibby Sterilin Bench Guard with the second material having a much greater 30 absorbancy and void volume.
WO 2007/096642 PCT/GB2007/000643 22 Where the double sided tape is of the same diameter or smaller then the BANA film (12mm diameter or less) - as in Figure 3B - then it was seen that the 'sample' wicked from the sample pad into the sink via the gauze fibres or directly through the PVA film such that the BANA film would be nearly dry after the initial sample incubation which 5 led to uneven and poor signal generation. Figure 12 is a digital image of booklets according to Figure 3B with and without a sink using 40 and 70pl sample volume showing effect of liquid removal from Sample Pad and Reduced Signal. The results are tabulated in Table 5. 10 Table 5 - Signal Generation for Booklets incorporating sink according to Figure 3B Papain Sample Volume 40pl Sample Volume 70pl Standard Control Sink Control Sink 50pg/ml ++ + + +/ 250pg/ml ++++ ++ ++++ ++ When the double sided tape was larger than the BANA film such that there was a 15 minimum of 1 mm excess around the whole BANA film (as shown below) it was found that device coped with sample volumes from 40 to - 2 0 0 pl of sample without excess not being mopped up by the sink. A diagram of such an embodiment is shown in Figure 13. Components of Figure 13 are as follows: DMAC/PVA Film 35; Double Sided Tape 36; BANA/PVA/Gauze Film 37; and sink/sump 38. A digital image of 20 booklets with and without sink tested using 150pt sample volume is shown in Figure 14. The results are tabulated in Table 6. Table 6 - Signal Generation for Booklets incorporating sink as shown in Figure 13 Papain Standard Control Sink 50pg/ml + + 250pg/ml +++ +++ 25
Claims (21)
1. An enzyme detection product for detecting the presence of an enzyme in a sample comprising: 5 a reaction zone for receiving a sample; a visualisation zone for presenting a signal in response to the detection of the activity of the enzyme; and a membrane interposable between the reaction zone and the visualisation zone, the membrane preventing passage from the reaction zone to 10 the visualisation zone of components having a size greater than a threshold size, wherein the reaction zone comprises a reactant capable of reacting with the enzyme in order to generate a reaction product having a size less than the threshold size. 15
2. An enzyme detection product according to claim 1 wherein the membrane is opaque.
3. An enzyme detection product according to claim 1 or 2 wherein the reaction zone and/or the visualisation zone comprise films made of an absorbent 20 material which hydrates but does not dissolve in the presence of water.
4. An enzyme detection product according to claim 3 wherein the film is made from PVA, pectin, acrylamide, agarose, pululan or a carrageenan. 25
5. An enzyme detection product according to any one of the preceding claims wherein the visualisation zone is made from a material which allows uniform colour development.
6. An enzyme detection product according to any one of the preceding claims 30 wherein the reaction zone and the visualisation zone are hingedly connected to each other and may be brought into contact with each other by flexing about the hinge. WO 2007/096642 PCT/GB2007/000643 24
7. An enzyme detection product according to any one of the preceding claims wherein at least one of the reaction zone and visualisation zone has an adhesive area extending around its perimeter for sealingly contacting the reaction zone with the visualisation zone. 5
8. An enzyme detection product according to any one of the preceding claims wherein the visualisation zone is mounted on a leaf, there being provided an aperture in the leaf, for viewing of the visualisation zone. 10
9. An enzyme detection product according to claim 8 wherein the aperture is covered by a transparent window.
10. An enzyme detection product according to any one of the preceding claims wherein the reaction zone has a sump made from an absorbent material 15 located adjacent to it.
11. An enzyme detection product according to any one of the preceding claims wherein at least one of the reaction zone and visualisation zone is covered by a removable protective film. 20
12. An enzyme detection product according to any one of the preceding claims wherein the visualisation zone comprises a second reactant capable of reacting with the reaction product to generate the signal. 25
13. An enzyme detection product according to claim 12 wherein the enzyme is a protease; the first reactant being the BANA peptide and the second reactant being DMAC.
14. An enzyme detection product according to any one of the preceding claims 30 and further comprising a sample dispersion means for facilitating the lateral movement of the sample; breaking up the surface of the reaction zone and forming channels therein to conduct the sample therethrough. WO 2007/096642 PCT/GB2007/000643 25
15. A method of detecting the presence of an enzyme in a sample comprising the steps of: i) contacting the sample with a first reactant, the reactant producing a reaction product in the presence of the enzyme; 5 ii) separating at least some of the components in the mixture which are smaller than a threshold size into a visualisation zone, the reaction product being smaller than the threshold size; and 10 iii) detecting the presence of the reaction product in the visualisation zone.
16. A method according to claim 15 wherein step ii) comprises using a selective membrane to separate components in the mixture. 15
17. A method according to claim 15 or 16 wherein step ii) comprises observing the reaction product or a signal released by the reaction product.
18. A method according to any one of claims 15 to 17 wherein step i) is carried 20 out on a reaction substrate and step iii) is carried out on a visualisation substrate.
19. A method according to claim 18 and further comprising the step of, after step i), contacting the reaction substrate with the visualisation substrate. 25
20. A method according to any one of claims 15 to 19 wherein step iii) comprises providing a second reactant, which reacts with the reaction product to generate a signal. 30
21. A method according to any one of claims 15 to 20 using an enzyme detection product according to any one of claims 1 to 14.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0603664A GB2435510A (en) | 2006-02-23 | 2006-02-23 | Enzyme detection product and methods |
GB0603664.4 | 2006-02-23 | ||
PCT/GB2007/000643 WO2007096642A1 (en) | 2006-02-23 | 2007-02-23 | Enzyme detection |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2007217119A1 true AU2007217119A1 (en) | 2007-08-30 |
AU2007217119B2 AU2007217119B2 (en) | 2012-04-19 |
Family
ID=36178648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2007217119A Ceased AU2007217119B2 (en) | 2006-02-23 | 2007-02-23 | Enzyme detection |
Country Status (6)
Country | Link |
---|---|
US (2) | US8361386B2 (en) |
EP (1) | EP1986779A1 (en) |
JP (1) | JP5570729B2 (en) |
AU (1) | AU2007217119B2 (en) |
GB (1) | GB2435510A (en) |
WO (1) | WO2007096642A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2435510A (en) | 2006-02-23 | 2007-08-29 | Mologic Ltd | Enzyme detection product and methods |
GB2435512A (en) | 2006-02-23 | 2007-08-29 | Mologic Ltd | A binding assay and assay device |
GB2435511A (en) | 2006-02-23 | 2007-08-29 | Mologic Ltd | Protease detection |
GB2437311A (en) * | 2006-04-07 | 2007-10-24 | Mologic Ltd | A protease detection product |
GB2454672A (en) * | 2007-11-13 | 2009-05-20 | Mologic Ltd | Chromogenic protease substrates |
GB0904080D0 (en) | 2009-03-09 | 2009-04-22 | Mologic Ltd | Imaging method |
JP5860480B2 (en) | 2011-01-11 | 2016-02-16 | キャプシュゲル・ベルジウム・エヌ・ヴィ | New hard capsule containing pullulan |
US10024817B2 (en) | 2014-10-17 | 2018-07-17 | Pelogenix, Llc | Method for detecting proteases and active infection in biological fluids and tissues |
US10386376B2 (en) | 2015-11-09 | 2019-08-20 | Jeimei, Llc | Sample container with integrated test strip |
GB201605110D0 (en) | 2016-03-24 | 2016-05-11 | Mologic Ltd | Detecting sepsis |
US11576870B2 (en) | 2017-04-14 | 2023-02-14 | Capsugel Belgium Nv | Pullulan capsules |
EP3610028A1 (en) | 2017-04-14 | 2020-02-19 | Capsugel Belgium NV | Process for making pullulan |
GB201902458D0 (en) | 2019-02-22 | 2019-04-10 | Mologic Ltd | Treatment stratification for an excerbation of inflamation |
Family Cites Families (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA983358A (en) | 1971-09-08 | 1976-02-10 | Kenneth D. Bagshawe | Performance of chemical or biological reactions |
US4064770A (en) * | 1974-06-24 | 1977-12-27 | Vladimir Viktorovich Idel | Machine for sharpening band saw teeth |
US4055394A (en) | 1976-10-18 | 1977-10-25 | Akzona Incorporated | Diagnostic test card |
CA1095819A (en) * | 1977-01-14 | 1981-02-17 | Eastman Kodak Company | Element for analysis of liquids |
US4178153A (en) | 1977-11-21 | 1979-12-11 | Damon Corporation | Method and apparatus for chemical spot test analysis |
US4258001A (en) | 1978-12-27 | 1981-03-24 | Eastman Kodak Company | Element, structure and method for the analysis or transport of liquids |
JPS568549A (en) | 1979-07-02 | 1981-01-28 | Fuji Photo Film Co Ltd | Multilayer chemical analyzing material |
JPS5764160A (en) * | 1980-10-06 | 1982-04-19 | Yokogawa Hokushin Electric Corp | Method and apparatus for measuring urea |
JPS5767860A (en) | 1980-10-15 | 1982-04-24 | Fuji Photo Film Co Ltd | Material for multilayer analysis |
DE3247608A1 (en) | 1982-12-23 | 1984-07-05 | Boehringer Mannheim Gmbh, 6800 Mannheim | TEST STRIP |
US4851356A (en) | 1983-05-06 | 1989-07-25 | The Trustees Of Columbia University In The City Of New York | Immunoassay for human chorionic gonadotropin |
US4522923A (en) | 1983-10-03 | 1985-06-11 | Genetic Diagnostics Corporation | Self-contained assay method and kit |
US4703017C1 (en) | 1984-02-14 | 2001-12-04 | Becton Dickinson Co | Solid phase assay with visual readout |
JPS60224063A (en) | 1984-04-20 | 1985-11-08 | Terumo Corp | Testing implement |
US4632901A (en) | 1984-05-11 | 1986-12-30 | Hybritech Incorporated | Method and apparatus for immunoassays |
US4826759A (en) * | 1984-10-04 | 1989-05-02 | Bio-Metric Systems, Inc. | Field assay for ligands |
US5958790A (en) * | 1984-12-20 | 1999-09-28 | Nycomed Imaging As | Solid phase transverse diffusion assay |
US5879881A (en) | 1985-04-04 | 1999-03-09 | Hybritech, Incorporated | Solid phase system for use in ligand-receptor assays |
US5223403A (en) * | 1985-05-31 | 1993-06-29 | University Of Michigan | Device for diagnosing periodontal disease |
US4689240A (en) | 1985-06-20 | 1987-08-25 | Miles Laboratories, Inc. | Method for forming volume independent test device |
US4647430A (en) | 1985-06-20 | 1987-03-03 | Miles Laboratories, Inc. | Volume independent test device |
US5236826A (en) | 1985-12-10 | 1993-08-17 | Murex Corporation | Immunoassay for the detection or quantitation of an analyte |
JPS63305251A (en) | 1987-06-05 | 1988-12-13 | Dai Ichi Pure Chem Co Ltd | Immunoassay utilizing latex aggregation reaction |
FR2621393B1 (en) | 1987-10-05 | 1991-12-13 | Toledano Jacques | DEVICE FOR IMMUNOENZYMATIC DETECTION OF SUBSTANCES FROM A DROP OF BLOOD OR LIQUID FROM ANY BIOLOGICAL MEDIUM |
CA1331515C (en) * | 1987-12-24 | 1994-08-23 | Richard A. Mcleod | Recovery of silver from photo sensitive materials |
DE3814370A1 (en) | 1988-04-28 | 1989-11-09 | Boehringer Mannheim Gmbh | TEST PROVIDER FOR THE ANALYSIS OF A SAMPLING FLUID, METHOD FOR CARRYING OUT SUCH ANALYSIS AND METHOD OF PRODUCTION |
FR2630827B1 (en) | 1988-04-28 | 1994-06-03 | Oris Ind | APPARATUS AND METHOD FOR QUICK QUALITATIVE AND QUANTITATIVE DETERMINATION OF THE PRESENCE OF A REACTIVE LIGAND IN A FLUID |
US6352862B1 (en) | 1989-02-17 | 2002-03-05 | Unilever Patent Holdings B.V. | Analytical test device for imuno assays and methods of using same |
US5064770A (en) | 1989-08-01 | 1991-11-12 | Wisconsin Alumni Research Foundation | Assay for 1,25-dihydroxy vitamin d receptor protein |
US5185249A (en) | 1990-04-04 | 1993-02-09 | Eastman Kodak Company | Dry analytical element for assaying salicylate |
US5171662A (en) | 1990-09-13 | 1992-12-15 | The Upjohn Company | Method of detecting HIV protease activity |
JP2628792B2 (en) | 1990-09-26 | 1997-07-09 | アカーズ・リサーチ・コーポレーシヨン | Improved ligand assays |
AU9039691A (en) | 1990-11-14 | 1992-06-11 | Southern Research Institute | Rapid diagnostic device and kit |
EP0566695B1 (en) | 1991-01-11 | 1999-06-02 | Quidel Corporation | A one-step lateral flow assay and nonbibulous support used therein |
JP2517197B2 (en) | 1991-02-28 | 1996-07-24 | ベーリンガー・マンハイム・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Test carrier for measuring analytes in whole blood |
US5869345A (en) | 1991-05-29 | 1999-02-09 | Smithkline Diagnostics, Inc. | Opposable-element assay device employing conductive barrier |
GB9119102D0 (en) | 1991-09-07 | 1991-10-23 | Biosyn Ltd | Bioimmunassay |
DE4132743A1 (en) | 1991-10-02 | 1993-04-08 | Boehringer Mannheim Gmbh | TEST CARRIER FOR THE ANALYSIS OF LIQUIDS |
US5296192A (en) | 1992-04-03 | 1994-03-22 | Home Diagnostics, Inc. | Diagnostic test strip |
US5315143A (en) * | 1992-04-28 | 1994-05-24 | Matsushita Electric Industrial Co., Ltd. | High density integrated semiconductor device |
US5447846A (en) | 1992-07-17 | 1995-09-05 | Fuji Photo Film C., Ltd. | Homogeneous Immunoassay process using covalent conjugate of enzyme and plural monoclonal antibodies for different epitopes on analyte |
US5601986A (en) | 1994-07-14 | 1997-02-11 | Amgen Inc. | Assays and devices for the detection of extrahepatic biliary atresia |
US6686170B1 (en) | 1994-08-17 | 2004-02-03 | Abbott Laboratories | Assay devices with mobile control reagents |
AUPM769394A0 (en) | 1994-08-25 | 1994-09-15 | Commonwealth Scientific And Industrial Research Organisation | Assay for the detection of proteases |
US5607565A (en) * | 1995-03-27 | 1997-03-04 | Coulter Corporation | Apparatus for measuring analytes in a fluid sample |
US5755231A (en) | 1995-05-17 | 1998-05-26 | Plus Bio, Inc. | Test strip including integral specimen flow retarding structure |
US5741659A (en) | 1996-01-04 | 1998-04-21 | The United States Of America As Represented By The Secretary Of The Navy | Rapid microbial protease assay |
US6096563A (en) | 1996-03-29 | 2000-08-01 | Strategic Diagnostics Inc. | Dual particle immunoassay method and kit |
WO1998000703A1 (en) | 1996-07-03 | 1998-01-08 | Plus Bio, Inc. | Test strip including integral specimen flow retarding structure |
US5879951A (en) | 1997-01-29 | 1999-03-09 | Smithkline Diagnostics, Inc. | Opposable-element assay device employing unidirectional flow |
US7312302B2 (en) | 1997-02-20 | 2007-12-25 | Oncolmmunin, Inc. | Compositions for the detection of enzyme activity in biological samples and methods of use thereof |
US5939252A (en) * | 1997-05-09 | 1999-08-17 | Lennon; Donald J. | Detachable-element assay device |
US6040195A (en) | 1997-06-10 | 2000-03-21 | Home Diagnostics, Inc. | Diagnostic sanitary test strip |
DE69914164T2 (en) | 1998-06-24 | 2004-11-25 | Chen & Chen, LLC, Brookline | TEST COLUMN WITH SEVERAL LAYERS |
US6140136A (en) * | 1998-09-18 | 2000-10-31 | Syntron Bioresearch, Inc. | Analytical test device and method of use |
DE19916430C1 (en) | 1999-04-12 | 2001-01-18 | Inst Chemo Biosensorik | Apparatus for use in performing receptor ligand and affinity tests |
AU4344800A (en) | 1999-04-16 | 2000-11-02 | New York Blood Center, Inc., The | Monoclonal antibodies reactive with fibrin(ogen) degradation products generated by matrix metalloproteinases |
GB2350677A (en) | 1999-06-04 | 2000-12-06 | Cambridge Life Sciences | Enzyme detection |
JP2001000197A (en) | 1999-06-22 | 2001-01-09 | Fuji Photo Film Co Ltd | Measurement of protease activity |
GB9923384D0 (en) | 1999-10-05 | 1999-12-08 | Univ Birmingham | Fluid-flow control device |
GB9925461D0 (en) | 1999-10-27 | 1999-12-29 | Genosis Ltd | Assay device |
US6316205B1 (en) | 2000-01-28 | 2001-11-13 | Genelabs Diagnostics Pte Ltd. | Assay devices and methods of analyte detection |
IL140993A0 (en) * | 2000-05-15 | 2002-02-10 | Bayer Ag | Trypsin substrate and diagnostic device, and method of using same |
GB0015923D0 (en) * | 2000-06-30 | 2000-08-23 | Astrazeneca Ab | Methods |
US6750034B1 (en) | 2000-06-30 | 2004-06-15 | Ortho-Mcneil Pharmaceutical, Inc. | DNA encoding human serine protease D-G |
WO2002035216A1 (en) | 2000-10-25 | 2002-05-02 | Miller Michael M | Multilayer analytical element and method for determination of analytes in fluids containing interfering substances |
EP1358314A4 (en) | 2000-11-20 | 2008-06-25 | 20 20 Genesystems Inc | Methods, devices, arrays and kits for detecting and analyzing biomolecules |
KR100425525B1 (en) | 2000-11-21 | 2004-03-30 | 재단법인서울대학교산학협력재단 | Diagnostic agents for detecting premature birth, fetal infection and fetal damage and diagnostic kit containing the same |
FR2817961B1 (en) | 2000-12-08 | 2003-08-01 | Diagast | TEMPORARY SEPARATION BARRIER, CONTAINER COMPRISING SAME AND METHOD FOR IMPLEMENTING A TEST IN THIS CONTAINER |
US7531362B2 (en) | 2001-06-07 | 2009-05-12 | Medmira Inc. | Rapid diagnostic assay |
WO2003014698A2 (en) | 2001-08-07 | 2003-02-20 | Merck & Co., Inc. | Biological assay detection method |
AU2002341621A1 (en) | 2001-09-10 | 2003-03-24 | Meso Scale Technologies, Llc | Methods, reagents, kits and apparatus for protein function analysis |
AU2002359891A1 (en) | 2001-12-28 | 2003-07-24 | Polymer Technology Systems, Inc. | Test strip for determining concentration of triglycerides |
US7148030B2 (en) | 2002-02-01 | 2006-12-12 | Promega Corporation | Bioluminescent protease assay |
US7041453B2 (en) | 2002-08-22 | 2006-05-09 | Bioarray Solutions Ltd. | Molecular constructs and methods of use for detection of biochemical reactions |
AU2003295863A1 (en) | 2002-11-22 | 2004-06-18 | Marligen Biosciences, Inc. | Detection of protease enzymes |
JP4283634B2 (en) * | 2003-02-21 | 2009-06-24 | 国立大学法人富山大学 | Amylase activity measurement kit |
GB0311902D0 (en) * | 2003-05-22 | 2003-06-25 | Cambridge Life Sciences | Assay method and apparatus |
GB0316075D0 (en) | 2003-07-09 | 2003-08-13 | Molecular Sensing Plc | Protease detection assay |
GB0317680D0 (en) | 2003-07-29 | 2003-09-03 | Univ Edinburgh | Protease assay |
GB2410086A (en) | 2004-01-14 | 2005-07-20 | British Biocell Internat Ltd | Assay devices having flow block(s) to determine flow of liquids |
JP2008501935A (en) | 2004-06-04 | 2008-01-24 | プロテオム システムズ インテレクチュアル プロパティ プロプライエタリー リミテッド | Diagnostic test process and sample flow controlled device |
US7906276B2 (en) | 2004-06-30 | 2011-03-15 | Kimberly-Clark Worldwide, Inc. | Enzymatic detection techniques |
DK1899462T3 (en) * | 2005-07-02 | 2011-06-06 | Arecor Ltd | Stable aqueous systems comprising proteins |
GB2435512A (en) | 2006-02-23 | 2007-08-29 | Mologic Ltd | A binding assay and assay device |
GB2435511A (en) | 2006-02-23 | 2007-08-29 | Mologic Ltd | Protease detection |
GB2435510A (en) * | 2006-02-23 | 2007-08-29 | Mologic Ltd | Enzyme detection product and methods |
GB2437311A (en) | 2006-04-07 | 2007-10-24 | Mologic Ltd | A protease detection product |
JP2008012677A (en) * | 2006-06-30 | 2008-01-24 | Brother Ind Ltd | Image recorder |
GB2452076A (en) | 2007-08-23 | 2009-02-25 | Mologic Ltd | Detection of enzymes by detecting binding of substrate recognition molecules to modified substrates |
GB2454672A (en) * | 2007-11-13 | 2009-05-20 | Mologic Ltd | Chromogenic protease substrates |
GB0904080D0 (en) | 2009-03-09 | 2009-04-22 | Mologic Ltd | Imaging method |
GB0916749D0 (en) | 2009-09-23 | 2009-11-04 | Mologic Ltd | Peptide cleaning agents |
-
2006
- 2006-02-23 GB GB0603664A patent/GB2435510A/en not_active Withdrawn
-
2007
- 2007-02-23 US US12/280,290 patent/US8361386B2/en not_active Expired - Fee Related
- 2007-02-23 WO PCT/GB2007/000643 patent/WO2007096642A1/en active Application Filing
- 2007-02-23 EP EP07705274A patent/EP1986779A1/en not_active Withdrawn
- 2007-02-23 AU AU2007217119A patent/AU2007217119B2/en not_active Ceased
- 2007-02-23 JP JP2008555875A patent/JP5570729B2/en not_active Expired - Fee Related
-
2013
- 2013-01-03 US US13/733,438 patent/US8846328B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US8361386B2 (en) | 2013-01-29 |
WO2007096642A1 (en) | 2007-08-30 |
JP5570729B2 (en) | 2014-08-13 |
US8846328B2 (en) | 2014-09-30 |
JP2009527246A (en) | 2009-07-30 |
GB0603664D0 (en) | 2006-04-05 |
US20090191582A1 (en) | 2009-07-30 |
AU2007217119B2 (en) | 2012-04-19 |
GB2435510A (en) | 2007-08-29 |
EP1986779A1 (en) | 2008-11-05 |
US20130189719A1 (en) | 2013-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2007217119B2 (en) | Enzyme detection | |
US6846453B1 (en) | Housing of immunochromatography apparatus | |
FI83707C (en) | Testing means for functionality | |
KR20010076415A (en) | A test tool for a multi-item test and the method for producing the same as well as a measuring device for the test tool | |
US5366872A (en) | Test kits and methods for evaluating sterilization cycles | |
US4499185A (en) | Test for esterase activity in a liquid sample | |
JPH0721455B2 (en) | Tools and Methods for Analyzing Specific Components in Liquid Samples | |
JP2004004106A (en) | Multi-layer test device and method for fructosamine assay | |
EP1271143A4 (en) | Specimen having capability of separating solid component | |
EP2313785B1 (en) | A method and assembly for measuring thrombin generation in plasma | |
CN113242725B (en) | System for analyzing body fluids and wound-related biomolecules | |
US7674603B2 (en) | Microorganism detector | |
US7195922B1 (en) | Allergen detection | |
CA2764617A1 (en) | Methods and kits for detecting, diagnosing and monitoring diseases | |
JP2005172533A (en) | Testing tool, and measuring method | |
CN101251491A (en) | Cholinesterase visual observation color matching card and manufacture method thereof | |
EP3404418A2 (en) | A diagnostic strip for determining the amount of sarcosine, creatinine and hydrogen peroxide in a biological or environmental sample | |
US20230390761A1 (en) | Microbiology test card | |
WO2023147071A1 (en) | Rapid diagnostic test for antibiotic resistance, and methods of use and methods of making thereof | |
DE59811370D1 (en) | Methods for the detection and determination of enzymatic reactions in urine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |